Medical marijuana: Clearing away the smoke

Igor Grant, J. Hampton Atkinson, Ben Gouaux, Barth Wilsey

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Recent advances in understanding of the mode of action of tetrahydrocannabinol and related cannabinoid ingredients of marijuana, plus the accumulating anecdotal reports on potential medical benefits have spurred increasing research into possible medicinal uses of cannabis. Recent clinical trials with smoked and vaporized marijuana, as well as other botanical extracts indicate the likelihood that the cannabinoids can be useful in the management of neuropathic pain, spasticity due to multiple sclerosis, and possibly other indications. As with all medications, benefits and risks need to be weighed in recommending cannabis to patients. We present an algorithm that may be useful to physicians in determining whether cannabis might be recommended as a treatment in jurisdictions where such use is permitted.

Original languageEnglish (US)
Pages (from-to)18-25
Number of pages8
JournalOpen Neurology Journal
Volume6
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Medical Marijuana
Cannabis
Smoke
Cannabinoids
Dronabinol
Neuralgia
Multiple Sclerosis
Clinical Trials
Physicians
Research

Keywords

  • Cannabis
  • Chronic pain
  • Pain

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Neurology

Cite this

Grant, I., Hampton Atkinson, J., Gouaux, B., & Wilsey, B. (2012). Medical marijuana: Clearing away the smoke. Open Neurology Journal, 6(1), 18-25. https://doi.org/10.2174/1874205X01206010018

Medical marijuana : Clearing away the smoke. / Grant, Igor; Hampton Atkinson, J.; Gouaux, Ben; Wilsey, Barth.

In: Open Neurology Journal, Vol. 6, No. 1, 2012, p. 18-25.

Research output: Contribution to journalArticle

Grant, I, Hampton Atkinson, J, Gouaux, B & Wilsey, B 2012, 'Medical marijuana: Clearing away the smoke', Open Neurology Journal, vol. 6, no. 1, pp. 18-25. https://doi.org/10.2174/1874205X01206010018
Grant, Igor ; Hampton Atkinson, J. ; Gouaux, Ben ; Wilsey, Barth. / Medical marijuana : Clearing away the smoke. In: Open Neurology Journal. 2012 ; Vol. 6, No. 1. pp. 18-25.
@article{14715be95a9c49a0b99a54b440d82c8a,
title = "Medical marijuana: Clearing away the smoke",
abstract = "Recent advances in understanding of the mode of action of tetrahydrocannabinol and related cannabinoid ingredients of marijuana, plus the accumulating anecdotal reports on potential medical benefits have spurred increasing research into possible medicinal uses of cannabis. Recent clinical trials with smoked and vaporized marijuana, as well as other botanical extracts indicate the likelihood that the cannabinoids can be useful in the management of neuropathic pain, spasticity due to multiple sclerosis, and possibly other indications. As with all medications, benefits and risks need to be weighed in recommending cannabis to patients. We present an algorithm that may be useful to physicians in determining whether cannabis might be recommended as a treatment in jurisdictions where such use is permitted.",
keywords = "Cannabis, Chronic pain, Pain",
author = "Igor Grant and {Hampton Atkinson}, J. and Ben Gouaux and Barth Wilsey",
year = "2012",
doi = "10.2174/1874205X01206010018",
language = "English (US)",
volume = "6",
pages = "18--25",
journal = "Open Neurology Journal",
issn = "1874-205X",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Medical marijuana

T2 - Clearing away the smoke

AU - Grant, Igor

AU - Hampton Atkinson, J.

AU - Gouaux, Ben

AU - Wilsey, Barth

PY - 2012

Y1 - 2012

N2 - Recent advances in understanding of the mode of action of tetrahydrocannabinol and related cannabinoid ingredients of marijuana, plus the accumulating anecdotal reports on potential medical benefits have spurred increasing research into possible medicinal uses of cannabis. Recent clinical trials with smoked and vaporized marijuana, as well as other botanical extracts indicate the likelihood that the cannabinoids can be useful in the management of neuropathic pain, spasticity due to multiple sclerosis, and possibly other indications. As with all medications, benefits and risks need to be weighed in recommending cannabis to patients. We present an algorithm that may be useful to physicians in determining whether cannabis might be recommended as a treatment in jurisdictions where such use is permitted.

AB - Recent advances in understanding of the mode of action of tetrahydrocannabinol and related cannabinoid ingredients of marijuana, plus the accumulating anecdotal reports on potential medical benefits have spurred increasing research into possible medicinal uses of cannabis. Recent clinical trials with smoked and vaporized marijuana, as well as other botanical extracts indicate the likelihood that the cannabinoids can be useful in the management of neuropathic pain, spasticity due to multiple sclerosis, and possibly other indications. As with all medications, benefits and risks need to be weighed in recommending cannabis to patients. We present an algorithm that may be useful to physicians in determining whether cannabis might be recommended as a treatment in jurisdictions where such use is permitted.

KW - Cannabis

KW - Chronic pain

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=84861858686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861858686&partnerID=8YFLogxK

U2 - 10.2174/1874205X01206010018

DO - 10.2174/1874205X01206010018

M3 - Article

C2 - 22629287

AN - SCOPUS:84861858686

VL - 6

SP - 18

EP - 25

JO - Open Neurology Journal

JF - Open Neurology Journal

SN - 1874-205X

IS - 1

ER -